(National Physical Laboratory) A new research paper sheds light on the way antibodies distinguish between different but closely related "biomarkers" -- proteins which reveal information about the condition of the human body.
This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases.